Nerve Repair And Regeneration Market To Reach USD 25.67 Billion By 2032, Driven By Breakthroughs In Neurostimulation And Biomaterials SNS Insider

(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider Analyzes the U.S. Nerve Repair and Regeneration Market's Surge to USD 6.45 Billion by 2032-As the Country Leads Global Adoption of Advanced Neurostimulation Devices and Cost-Effective Biosimilar Therapies

Austin, July 02, 2025 (GLOBE NEWSWIRE) -- Nerve Repair and Regeneration Market Size & Growth Analysis:

According to SNS Insider, the global Nerve Repair and Regeneration Market was valued at USD 9.14 billion in 2023 and is projected to reach USD 25.67 billion by 2032, expanding at a CAGR of 12.19% during the forecast period of 2024–2032.

Innovation in neurostimulation and biomaterials is reshaping the treatment of peripheral nerve injury with more targeted, efficient, and minimally invasive approaches. Digital neurostimulation devices - weighty features such as spinal cord and deep brain stimulators can be used to control chronic neurological conditions and alleviate pain. Meanwhile, advanced biomaterials employed in nerve grafts, conduits, and scaffolds stimulate faster and more physiological nerve recovery.

Get a Sample Report of Nerve Repair and Regeneration Market@

The U.S. Nerve Repair and Regeneration Market was estimated at USD 2.31 billion in 2023 and is expected to reach USD 6.45 billion by 2032, at a CAGR of 12.11% during the forecast period of 2024-2032

In the U.S, there has been early and increasing use of biosimilar erythropoietin products, which have been proven to be more cost-effective than original biologics. This change is increasing the availability of EPO therapies within the dialysis and oncology settings. Physician adoption and healthcare system uptake of biosimilars are now being incentivised by guidelines from the FDA and payer incentives, to drive the overall market.Top of Form

Major Players Analysis Listed in this Report are:

• Axogen Inc. (Avance Nerve Graft, AxoGuard Nerve Connector)
• Integra LifeSciences (NeuraGen Nerve Guide, NeuraWrap Nerve Protector)
• Polyganics (NEUROLAC Nerve Guide, VIVOSORB Adhesion Barrier)
• Regenity (Neuroflex Nerve Conduit, NEUROCAP Nerve Capping Device)
• Synovis Micro Companies Alliance (a subsidiary of Baxter) (Neurotube, GEM Microvascular Clamps)
• Collagen Matrix Inc. (Neuroflex, NeuroMatrix)
• Toyobo Co., Ltd. (Nerbridge, Nerbridge Plus)
• Orthomed S.A.S. (Revolnerv, NeuroWrap)
• Inova MedTech (Neuroflex Collagen Nerve Conduit, NeuroMend Collagen Membrane)
• Stryker Corporation (NeuroMatrix, Neuroflex)
• Alafair Biosciences (VersaWrap Nerve Protector, VersaWrap Tendon Protector)
• Checkpoint Surgical (NeuroShield Chitosan Nerve Wrap, Checkpoint Stimulator/Locator)
• Medovent GmbH (Reaxon Nerve Guide, Reaxon Plus)
• KeriMedical (Reaxon Nerve Guide, Reaxon Plus)
• BioWave Corporation (BioWaveHOME Neuromodulation Device, BioWavePRO Neuromodulation Device)
• Neuroregen LLC (Neuroregen Nerve Conduit, Neuroregen Nerve Wrap)
• Neurotex Ltd. (Neurotex Nerve Guide, Neurotex Nerve Wrap)
• Orthomed S.A.S. (Revolnerv, NeuroWrap)
• Alafair Biosciences (VersaWrap Nerve Protector, VersaWrap Tendon Protector)
• Mimtb (AxoGuard Nerve Protector, Avance Nerve Graft)

Nerve Repair and Regeneration Market Report Scope

Report Attributes	Details
Market Size in 2023	US$ 9.14 billion
Market Size by 2032	US$ 25.67 billion
CAGR	CAGR of 12.19% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Regional Analysis	North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)

Segment Analysis:

Neurostimulation and Neuromodulation Devices Segment is Anticipated to Hold the Largest Share of the Nerve Repair and Regeneration Market By Product

In 2023, the neurostimulation and neuromodulation devices segment held the largest market share with 67%. The growing aging population is significantly contributing to the dominance of neurostimulation and neuromodulation devices. Older adults are more susceptible to chronic conditions such as Parkinson's disease, neuropathic pain, and spinal disorders, which require long-term management. These devices offer effective, minimally invasive solutions, making them ideal for elderly patient care.

Based on Surgery, the Neurostimulation and Neuromodulation Surgeries Segment Accounted for the Largest Share of the Nerve Repair and Regeneration Market

The drug development segment dominated the nerve Repair and Regeneration Market in 2023 with a 38% market share, due to the increasing demand for pharmacological therapies aimed at nerve protection, regeneration, and pain management. Advancements in neuroprotective agents, growth factors, and stem cell-based drugs have driven interest from both academia and pharmaceutical companies. Additionally, a surge in clinical trials and R&D investments targeting neurological conditions such as neuropathy, multiple sclerosis, and spinal cord injuries has strengthened this segment's lead.

For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@

Nerve Repair and Regeneration Market Segmentation

By Product

• Biomaterials
• Neurostimulation and Neuromodulation Devices
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices

By Surgery

• Direct Nerve Repair/Neurorrhaphy
• Stem Cell Therapy
• Nerve Grafting
• Neurostimulation and Neuromodulation Surgeries

Nerve Repair and Regeneration Market is Expected to Register Fastest Growth in Asia-Pacific, North America Dominates.

The Nerve Repair and Regeneration Market in North America accounted for the largest share in 2023, with a 32% market share, owing to the region's well-established healthcare infrastructure, high prevalence of neurological disorders, and increased incidence of traumatic injuries. Additionally, strong government funding, early adoption of advanced neurostimulation technologies, and the presence of major players such as Medtronic, Abbott, and Boston Scientific contribute to continuous innovation and accessibility. Favorable FDA approvals and reimbursement policies further support market growth in the region.

The region Asia-Pacific is estimated to grow at the highest CAGR during the forecast period, owing to the rising prevalence of chronic kidney disease and cancer, increasing healthcare spending, expanding dialysis centers, growing awareness of anemia treatments, and improving access to biosimilar EPO therapies.

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

5.1 Prescription Trends and Treatment Patterns (2023)

5.2 Device and Drug Volume Metrics (Production and Usage)

5.3 Healthcare Expenditure Allocation (2023)

5.4 Clinical Trials and Regulatory Trends

6. Competitive Landscape

7. Nerve Repair and Regeneration Market by Product

8. Nerve Repair and Regeneration Market by Surgery

9. Regional Analysis

10. Company Profiles

11. Use Cases and Best Practices

12. Conclusion

Buy a Single-User PDF of Nerve Repair and Regeneration Market Analysis & Outlook Report 2024-2032@

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: ...

MENAFN02072025004107003653ID1109752170